The Pot Book – Table of Contents

Foreword by Lester Grinspoon, M.D.
Introduction

Part One: An Overview of Cannabis
Introduction to Part One
1. The Subjective Effects of Cannabis □ Carl L. Hart, Ph.D., and Matthew G. Kirkpatrick
2. Early/Ancient History □ Chris Bennett
3. Recent History □ David Malmo-Levine
4. The Botany of Cannabis □ Lyle E. Craker, Ph.D., and Zoë Gardner
5. Cannabis Grow Revolution □ Danny Danko
6. The Endocannabinoid System □ Gregory L. Gerdeman, Ph.D., and Jason B. Schechter, Ph.D.
7. Anandamide and More □ Raphael Mechoulam, Ph.D., and Lumir Hanuš
8. Cannabis Laws in the United States □ Allen St. Pierre
9. On Ending Prohibition □ Ethan Nadelmann, J.D., Ph.D.

Part Two: Risks of Use and Harm Reduction
Introduction to Part Two
10. Medical Risks and Toxicology □ William Holubek, M.D.
11. Pulmonary Harm and Vaporizers □ Mitch Earleywine, Ph.D.
12. Cognitive Impairment from Chronic Use □ Caroline B. Marvin and Carl L. Hart, Ph.D.
13. Mental Health Risks Associated with Cannabis Use □ Cheryl Corcoran, M.D.
14. How Real Is the Risk of Addiction? □ Ryan Vandrey, Ph.D. and Margaret Haney, Ph.D.
15. Driving Under the Influence □ Paul Armentano
16. Arrest Statistics and Racism □ Harry G. Levine, Ph.D.
17. Getting Busted Is Not So Funny: An Interview with Tommy Chong □ Julie Holland, M.D.
18. The Collateral Consequences of Cannabis Convictions □ Richard Glen Boire, J.D.
19. Harm Reduction Psychotherapy □ Andrew Tatarsky, Ph.D.

Part Three: The Clinical Use of Cannabis
Introduction to Part Three
20. The Clinical Applications of Medical Marijuana: An Interview with Andrew Weil,M.D. □ Julie Holland, M.D.
21. Medical Marijuana Research: An Interview with Donald Abrams, M.D. □ Julie Holland, M.D.
22. MAPS and the Federal Obstruction of Medical Marijuana Research □ Rick Doblin, Ph.D.
23. The Government’s Pot Farm: An Interview with Mahmoud A. ElSohly, Ph.D. □ Julie Holland, M.D.
24. Cannabinoids and Psychiatry □ Julie Holland, M.D.
25. Cannabinoids and Neuroprotection □ Sunil K. Aggarwal, M.D., Ph.D., and Gregory T. Carter, M.D.
26. Cannabis and HIV/AIDS □ Mark A. Ware, M.D., and Lynne Belle-Isle
27. Multiple Sclerosis and Spasticity □ Denis J. Petro, M.D.
28. Pain Management □ Mark S. Wallace, M.D., and Ben Platt, M.D.
29. Sativex □ William Notcutt, M.D.

Part Four: Cannabis Culture
Introduction to Part Four
30. What to Tell the Children □ Marsha Rosenbaum, Ph.D.
31. Pot, Parenting, and Outing Myself □ Neal Pollack
32. Cannabis: Stealth Goddess □ Doug Rushkoff
33. Gardener’s Rights, Forgetting, and Co-Evolution: An Interview with Michael Pollan □ Julie Holland, M.D.
34. Cannabis, Business, and Philanthropy: An Interview with Peter Lewis □ Julie Holland, M.D.
35. Thots on Pot □ Jeremy Wolff

Part Five: Steps in the Right Direction
Introduction to Part Five
36. Patients Out of Time: An Interview with Al Byrne, L.CDR. (retired) and Mary Lynn Mathre, R.N., C.A.R.N. □ Julie Holland, M.D.
37. Prescribing Cannabis in California □ Jeffrey Hergenrather, M.D.
38. Canadian Compassion Clubs □ N. Rielle Capler, M.H.A.
39. Dutch Drug Policy □ Mario Lap
40. A Cost Benefit Analysis of Legalizing Marijuana □ Jeffrey Miron, Ph.D.
41. The Marijuana Policy Project □ Bruce Mirken
42. The ACLU and Cannabis Drug Policy □ An Interview with Graham Boyd, J.D.

Resources Section
References
Contributors
Index

Would love to see Nick Sand's input. His articles on DMT are really good.